Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein lateral stalk subunit P0 pseudogene 6 (RPLP0P6) is classified as a pseudogene in the human genome. It shares sequence similarity with the functional gene encoding ribosomal protein P0—a component of the large ribosomal subunit that is essential in protein synthesis as part of the ribosome. However, RPLP0P6 itself is annotated as a pseudogene, meaning it is not believed to produce a functional protein product. Like other processed pseudogenes within this gene family, it may retain sequence resemblance but lacks confirmed biological activity or involvement in ribosomal assembly or translation. No documented role as a therapeutic target, disease association, or drug interaction has been established for RPLP0P6[3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein lateral stalk subunit P0 pseudogene 6 (RPLP0P6).